|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Trandolapril#Adult Indications and Dosage]] |
| {{Trandolapril}}
| |
| {{CMG}}; {{AE}} {{AM}}
| |
| | |
| ==Indications and Usage==
| |
| | |
| ====Hypertension====
| |
| MAVIK is indicated for the treatment of [[hypertension]]. It may be used alone or in combination with other antihypertensive medication such as [[hydrochlorothiazide]].
| |
| | |
| | |
| ====Heart Failure Post Myocardial Infarction or Left-Ventricular Dysfunction Post Myocardial Infarction====
| |
| MAVIK is indicated in stable patients who have evidence of [[left-ventricular systolic dysfunction]] (identified by wall motion abnormalities) or who are symptomatic from [[congestive heart failure]] within the first few days after sustaining [[acute myocardial infarction]]. Administration of trandolapril to Caucasian patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risk of heart failure-related hospitalization.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MAVIK (TRANDOLAPRIL) TABLET [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad67ea2-409c-4f52-a9b8-38216209609a | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |